Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ORELABRUTINIB: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

63.8%
Female
36.2%
Male

Age Information

The average age of patients reporting adverse events with ORELABRUTINIB is 66.0 years.

Geographic Distribution

The majority of adverse event reports for ORELABRUTINIB originate from CN.

Report Summary & Outcomes

131
Total Reports
131
As Primary/Secondary Suspect
29
Deaths Reported
12
Hospitalizations
10
Life-Threatening
4
Disabilities

Reporting Timeline

First adverse event report: 20221023. Most recent report: 20250819. View full timeline →

More About ORELABRUTINIB

ORELABRUTINIB Full Profile Reports by Year Drug Interactions